Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Travis Perkins PLC Director's Dealing 2026

Mar 19, 2026

5270_dirs_2026-03-19_d86aeb39-7d02-4956-b940-070eb40ec137.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3755X

Travis Perkins PLC

19 March 2026

Travis Perkins plc (the "Company") announces that :

On 19 March 2026 it was notified of the exercise of nil-cost options and subsequent sale of ordinary shares in the Company of 11.205105p ("Shares") to meet the income tax and national insurance liabilities arising from the exercise of options by Duncan Cooper, Chief Financial Officer and a Person Discharging Managerial Responsibilities ("PDMR"):

Name Status No. of options exercised Exercise & sale date No. of shares sold Price No. of shares retained
Duncan Cooper PDMR CFO Buyout Award of 2023 DSBP 13,973 19 March 2026 6,591 £5.635634 7,382

This Notification is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation, the Notification of Dealing Forms for the PDMR can be found below.

For further information please contact:

Will Lang

Company Secretary

[email protected]

+44 (0) 7468 713734

Notification of Dealing Form - Exercise of CFO Buyout Award of 2023 DSBP

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Duncan Cooper
2 Reason for the notification
a) Position/Status Chief Financial Officer/PDMR
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Travis Perkins plc
b) LEI 2138001I27OUBAF22K83
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and; (iv) each place where transaction have been conducted
a) Description of the financial

instrument, type of instrument

Identification code
Ordinary shares of 11.205105 pence each

ISIN: GB00BK9RKT01
b) Nature of the transaction Exercise of CFO Buyout Award of 2023 DSBP granted as nil-cost options under the Travis Perkins plc Restricted Share Plan
c) Price(s) and volume (s)
Price(s) Volume(s)
Nil 13,973
d) Aggregated information

-Aggregated volume

-Price
Aggregate

Price
Aggregate

Volume
Aggregate

Total
Nil 13,973 n/a
e) Date of the transaction 19 March 2026
f) Place of the transaction Outside a trading venue

Notification of Dealing Form - subsequent sale of ordinary shares by the PDMR

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Duncan Cooper
2 Reason for the notification
a) Position/Status Chief Financial Officer/PDMR
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Travis Perkins plc
b) LEI 2138001I27OUBAF22K83
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and; (iv) each place where transaction have been conducted
a) Description of the financial

instrument, type of instrument

Identification code
Ordinary shares of 11.205105 pence each

ISIN: GB00BK9RKT01
b) Nature of the transaction Sale of ordinary shares to meet income tax and national insurance liabilities falling due on exercise of CFO Buyout Award of 2023 DSBP granted as nil-cost options under the Travis Perkins plc Restricted Share Plan
c) Price(s) and volume (s)
Price(s) Volume(s)
£5.635634 6,591
d) Aggregated information

-Aggregated volume

-Price
Aggregate

Price
Aggregate

Volume
Aggregate

Total
£5.635634 6,591 £37,144.46369
e) Date of the transaction 19 March 2026
f) Place of the transaction XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFVRVVIALIR